Preview

Journal Infectology

Advanced search

Vaccination of pregnant women against controlled respiratory tract infections

https://doi.org/10.22625/2072-6732-2020-12-2-30-37

Abstract

The review provides information on the importance of immunoprophylaxis of epidemic controlled infections in pregnant women. It is shown that the most severe complications of pregnancy occur when women are infected with respiratory pathogens, especially influenza virus in the late stages of gestation. Newborns also have a high risk of fatal disorders and an infant mortality rate in cases of maternal influenza. Modern inactivated vaccines used in pregnant women in many countries since the second period of gestation have high safety and immunological efficacy for both women and the fetus. The issues of expediency, safety and effectiveness of vaccination of pregnant women against pneumococcus, Hemophilus type-b and pertussis infection are actively discussed, which reflects the evolution of understanding of the importance of this area of preventive medicine in obstetric
practice.

About the Authors

A. P. Cherdantsev
Ulyanovsk State University
Russian Federation
Ulyanovsk 


M. P. Kostinov
Research Institute for Vaccines and Sera named after I.I. Mechnikov, First Moscow State Medical University named after I.M. Sechenov
Russian Federation
Moscow



A. D. Shmitko
Research Institute for Vaccines and Sera named after I.I. Mechnikov,
Russian Federation
Moscow



A. A. Cherdantseva
Ulyanovsk State University
Russian Federation
Ulyanovsk 


References

1. Dobrohodova U.E., Gankovskaya L.V., Bahareva I.V., Svitich O.A. Rol immunnih mehanizmov v patogeneze nevinashivaniya beremennosti. J.Akusherstvo I ginekologiya 2016;7:5-10.

2. Steinborn A., Schmitt E., Kisielewicz A. et al. Pregnancyassociated diseases are characterized by the composition of the systemic regulatory T cell (Treg) pool with distinct subsets of Tregs. Clin Exp Immunol. 2012; 167(1): 84-98.

3. Warning J.C., McCracken S.A., Morris J.M. A balancing act: mechanisms by which the fetus avoids rejection by the maternal immune system. Reproduction. 2011; 141(6): 715-724.

4. Sevostianova O.U., Teplova S.N., Radzinskii V.E. Immunnii gomeostaz v dinamike neoslognennoi beremennosti. Vestnik RUDN. Medicina. Akusherstvo I ginekologiya 2005; 4(32): 39-42.

5. Rebrov B.A., Rebrova O.A., Komarov E.B. Simpozium “Pnevmonii u beremennih” Novosti medicine I farmacii 2011;18(387). http://www.mif-ua.com/archive/article/22734

6. Tarbaeva D.A., Kostinov M.P., Zagorodnay E.D. Akusherskie I perinatalnie ishodi beremennosti, oslojnennoi ostroi respiratornoi infekciei vo vtorom trimester gestacii J.Akusherstvo I ginekologiya. 2012; 2: 67-71.

7. Tarbaeva D.A., Kostinov M.P., Iozefson S.A., Zagorodnjaja Je.D. Klinicheskoe techenie i ishody grippa A (H1N1) 2009 u beremennyh. Zhurnal mikrobiologii, jepidemiologii i immunologii.2011; 4: 71-76.

8. Kuz’min V.N. Problema virusa grippa H1N1 i osobennosti zabolevanija u zhenshhin vo vremja beremennosti. Lechashhij vrach. 2010;1:66-68.

9. Belokrinickaja T.E., Tarbaeva D.A., Trubicyna A.Ju. i dr. Osobennosti techenija svinogo grippa u pogibshih beremennyh i v sluchajah, edva ne zavershivshihsja letal’nym ishodom. Lechashhij vrach. 2013; 3: 31-36.

10. Siston A.M., Rasmussen S.A., Honein M.A. et al. Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA. 2010; 303(15): 1517-1525.

11. Ortiz J.R., Englund J.A., Neuzil K.M. Influenza vaccine for pregnant women in resource-constrained countries: a review of the evidence to inform policy decisions. Vaccine. 2011; 29(27): 4439-4452.

12. ANZIC Influenza Investigators and Australian Maternity Outcomes Surveillance System. Critical illness due to 2009 A/H1N1 influenza in pregnant and posrpartum women: population based cohort study. BMJ. 2010; 340:1279.

13. Pebody R.G., MCLean E., Zhao H. et al. Pandemic influenza A (H1N1) 2009 and mortally in the United Kindom: risk factors for dears, April 2009 to March 2010. Euro Surveil. 2010;15(20):19571.

14. ECDC scientific advice on seasonal influenza vaccination of children and pregnant women: ECDC Technical report/European Centre for Disease Prevention and Control. Stockholm. ECDC. 2012:68.

15. Kostinov M.P., Cherdancev A.P., Savis’ko A.A. i dr. Istinnye i lozhnye reakcii na vvedenie vakciny protiv grippa u beremennyh. Voprosy ginekologii, akusherstva i perinatologii. 2011; 10(6): 44-48.

16. Kostinov MP, Cherdancev AP. Klinicheskaja i immunologicheskaja bezopasnost’ inaktivirovannoj immunoad#juvantnoj sub#edinichnoj vakciny protiv grippa dlja beremennyh. Akusherstvo i ginekologija. 2016;2:64-69.

17. Cherdancev A.P., Kostinov M.P., Kusel’man A.I. Vakcinoprofilaktika grippa u beremennyh. Rukovodstvo dlja vrachej. M.: Gruppa MDV; 2018.112с.

18. Shmit’ko A.D., Novikova S.V., Bocharova I.I., Jakubina A.A., Kostinov M.P. Mehanizmy i faktory, vlijajushhie na transplacentarnuju peredachu antitel klassa IgG v sisteme mat’-placenta-plod. Rossijskij vestnik akushera-ginekologa. 2014;6(14):27-31.

19. Bocharova I.I., Kostinov M.P., Novikova S.V., Shmit’ko A.D., i dr. Transplacentarnye antitela k virusu kori u novorozhdennyh pri razlichnom techenii beremennosti u ih materej. Rossijskij vestnik akushera-ginekologa. 2014;2(14): 14-18.

20. Kostinov M.P., Shmit’ko A.D., Bocharova I.I., Cherdancev A.P., i dr. Uroven’ IgG-antitel k virusu kori v pupovinnoj krovi novorozhdennyh s uchetom vozrasta materej. Jepidemiologija i infekcionnye bolezni. 2014;3:30-34.

21. American College of Obstetrics and Gynecology. AGOC committee opinion. Immunization during pregnancy. Obstet Gynecol. 2003; 101(1): 207-212.

22. Cherdancev A.P, Kusel’man A.I, Sinicina M.N, Shaljagina M.E, i dr. Izuchenie klinicheskoj bezopasnosti vakcinacii protiv grippa u beremennyh. Medicinskij al’manah. 2011;4:120-122.

23. Cherdancev A.P, Kusel’man A.I, Kostinov M.P, i dr. Razvitie v postnatal’nom periode detej, rozhdennyh ot vakcinirovannyh protiv grippa beremennyh. Ul’janovskij medikobiologicheskij zhurnal. 2012;3:80-84.

24. Cherdancev A.P, Kostinov M.P, Kusel’man A.I, i dr. Analiz ante- i postnatal’nogo razvitija detej na fone vakcinacii beremennyh protiv grippa. Rossijskij vestnik perinatologii i pediatrii. 2013;58(2): 30-34.

25. Kostinov M.P., Cherdancev A.P. Sostojanie zdorov’ja grudnyh detej, rozhdennyh ot vakcinirovannyh protiv grippa beremennyh. Pediatrija. 2016; 95(1): 67-71.

26. Centers for Disease Control and Prevention. Guidelines for vaccinating pregnant women (2016). Available at: http://www.cdc.gov/vaccines/pubs/preg-guide.htm#ppsv23

27. Kostinov M.P., Cherdantsev A.P. et al. Immunogenicity and safety of subunit influenza vaccines in pregnant women. ERJ Open Research. 2018; 4: 00060-2017. DOI: 10.1183/23120541.00060-2017

28. Kostinov M.P., Pahomov D.V., Magarshak O.O., Suhinin M.V. Vakcinoprofilaktika pnevmokokkovoj infekcii kak odnoj iz prichin oslozhnenij i letal›nosti pri grippe. Voprosy sovremennoj pediatrii. 2009; 8(6):131–134.

29. Marinos C. Makris, Konstantinos A. Polyzos, Michael N. Mavros et al. Safety of Hepatitis B, Pneumococcal Polysaccharide and Meningococcal Polysaccharide Vaccines in Pregnacy. Drug Saf. 2012; 35: 1. https://doi.org/10.2165/11595670-000000000-00000

30. Laibl V.R., Sheffield J.S. Influenza and pneumonia in pregnancy. Clin Perinatol. 2005; 32(3): 727-738.

31. Pnevmokokkovye vakciny: dokument po pozicii VOZ. 2012; 87 (14): 129–144. http://www.who.int/immunization/position _papers/WHO_PP_ pneumococcal_2012_RU.pdf

32. Munoz F.M., Englund J.A., Cheesman C.C. et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine. 2001; 20(5–6): 826-837.

33. Briko N.I., red. Immunoprofilaktika pnevmokokkovyh infekcij. Uchebno-metodicheskoe posobie. М.: 2013. 278.

34. Chuchalin A.G., Bilichenko T.I., Osipova G.L., i dr. Vakcinoprofilaktika boleznej organov dyhanija v ramkah pervichnoj mediko-sanitarnoj pomoshhi naseleniju. Klinicheskie rekomendacii. Pul›monologija. Prilozhenie. 2015; 2(25): 1-19.

35. Rehana A Salam, Jai K Das, Chesarahmia Dojo Soeandy, Zohra S Lassi, Zulfiqar A Bhutta. Impact of Haemophilus influenzae type B (Hib) and viral influenza vaccinations in pregnancy for improving maternal, neonatal and infant health outcomes Cochrane Pregnancy and Childbirth Group. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009982.pub2/full

36. Protasov A.D., Zhestkov A.V., Lavrent’eva N.E., Kostinov M.P., Ryzhov A.A. Jeffekt kompleksnoj vakcinacii protiv pnevmokokkovoj, gemofil’noj tipa b infekcij i grippa u pacientov s hronicheskoj obstruktivnoj bolezn’ju legkih. Zhurnal mikrobiologii, jepidemiologii i immunobiologii. 2011; 4: 80–84.

37. Jennifer L. Liang, Tejpratap Tiwari, Pedro Moro, et.al. Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP) / April 27. 2018; 67(2):1–44

38. Amirthalingam G., Andrews N., Campbell H., Ribeiro S. et al. Effectiveness of maternal pertussis vaccination in England: an observational study. Lancet. 2014; 384(9953):1521–8.

39. Dabrera G., Amirthalingam G., Andrews N., Campbell H., et al. A case-control study to estimate the effectiveness of maternal pertussis vaccination in protecting newborn infants in England and Wales, 2012–2013. Clin Infect Dis. 2015; Feb 1;60(3):333-7. doi: 10.1093/cid/ciu821.

40. The immunological basis for immunization series: module 4: pertussis (Immunological basis for immunization series; module 4/ update 2017) /http://www.who.int/immunization/documents/WHO_IVB_ISBN9789241513173/en/

41. Roger Baxter et al. Effectiveness of Vaccination During Pregnancy to Prevent Infant Pertussis. Pediatrics, 2017; doi:10.1542/peds.2016-4091

42. Vakciny protiv kokljusha: dokument po pozicii VOZ – avgust 2015 goda. Ezhenedel’nyj jepidemiologicheskij bjulleten’. 2015; 90(35): 433–460. http://www.who.int/wer

43. Safety of Tetanus, Diphtheria, and Pertussis Vaccination During Pregnancy: A Systematic Review. Obstetrics & Gynecology. 2017; doi: 10.1097/AOG.0000000000001888

44. Informacionnyj bjulleten’ o vakcinah http://www.immunize.org/VIS/russian_tdap.pdf

45. Update on Immunization and Pregnancy: Tetanus, Diphtheria, and Pertussis Vaccination. Committee on Obstetric Practice Immunization and Emerging Infections Expert Work Group/Number 7.18, September 2017 https://www.acog.org/Resources_And_Publications/ Committee_Opinions/Committee_on_Obstetric_Practice

46. Zverev V. V., Haitov R. M. red. Vakciny i vakcinacija. Nacional’noe rukovodstvo. Kratkoe izd. M.: GJeOTAR-Media, 2014:640.

47. Pruckova E.V., Cherdancev A.P, Andreeva N.P. Vakciny i vakcinacija protiv kokljusha detej i vzroslyh. Infekcionnye bolezni: novosti, mnenija, obuchenie. 2018;14(2):71-77.


Review

For citations:


Cherdantsev A.P., Kostinov M.P., Shmitko A.D., Cherdantseva A.A. Vaccination of pregnant women against controlled respiratory tract infections. Journal Infectology. 2020;12(2):30-37. (In Russ.) https://doi.org/10.22625/2072-6732-2020-12-2-30-37

Views: 1200


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-6732 (Print)